Tissue response to subcutaneously implanted recombinant spider silk: An in vivo study

79Citations
Citations of this article
113Readers
Mendeley users who have this article in their library.

Abstract

Spider silk is an interesting biomaterial for medical applications. Recently, a method for production of recombinant spider silk protein (4RepCT) that forms macroscopic fibres in physiological solution was developed. Herein, 4RepCT and Mersilk™(control) fibres were implanted subcutaneously in rats for seven days, without any negative systemic or local reactions. The tissue response, characterised by infiltration of macrophages and multinucleated cells, was similar with both fibres, while only the 4RepCT-fibres supported ingrowth of fibroblasts and newly formed capillaries. This in vivo study indicates that 4RepCT-fibres are well tolerated and could be used for medical applications, e.g., tissue engineering. © 2009 by the authors.

Cite

CITATION STYLE

APA

Fredriksson, C., Hedhammar, M., Feinstein, R., Nordling, K., Kratz, G., Johansson, J., … Rising, A. (2009). Tissue response to subcutaneously implanted recombinant spider silk: An in vivo study. Materials, 2(4), 1908–1922. https://doi.org/10.3390/ma2041908

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free